To search for genes in addition to the p19Arf-p53 pathway that can promote sarcoma development, in the future we plan to perform an in vivo CRISPR/Cas9 screen in immune competent mice for genes that can cooperate with Trp53 mutation. This evidence concerns the gene TP53 and sarcoma.